| SC 13G/A | 2022-01-27 | Canaan IX L.P. | ARVINAS, INC. | 0 | 0.0% | EDGAR |
| SC 13G | 2021-09-20 | PFIZER INC | ARVINAS, INC. | 3,457,815 | 6.6% | EDGAR |
| SC 13G/A | 2021-02-16 | Crews Craig Martin | ARVINAS, INC. | 1,382,392 | 2.9% | EDGAR |
| SC 13G/A | 2021-02-10 | RA CAPITAL MANAGEMENT, L.P. | ARVINAS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | ARVINAS, INC. | 5,090,038 | 10.5% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | ARVINAS, INC. | 2,815,747 | 5.9% | EDGAR |
| SC 13G/A | 2021-01-28 | Canaan IX L.P. | ARVINAS, INC. | 3,589,554 | 8.8% | EDGAR |
| SC 13G | 2020-10-13 | FMR LLC | ARVINAS, INC. | 4,481,184 | 11.4% | EDGAR |
| SC 13G/A | 2020-02-14 | RA CAPITAL MANAGEMENT, L.P. | ARVINAS, INC. | 3,672,872 | 9.4% | EDGAR |
| SC 13G/A | 2020-02-14 | ORBIMED ADVISORS LLC | ARVINAS, INC. | 910,000 | 2.3% | EDGAR |
| SC 13G/A | 2020-02-14 | Crews Craig Martin | ARVINAS, INC. | 2,141,787 | 5.5% | EDGAR |
| SC 13G/A | 2020-02-13 | Nextech V Oncology S.C.S., SICAV-SIF | ARVINAS, INC. | 1,694,351 | 4.3% | EDGAR |
| SC 13G/A | 2020-02-06 | 5AM VENTURES III, L.P. | ARVINAS, INC. | 1,343,791 | 3.5% | EDGAR |
| SC 13G/A | 2020-02-06 | Canaan IX L.P. | ARVINAS, INC. | 4,489,554 | 13.3% | EDGAR |
| SC 13G | 2019-02-14 | RA CAPITAL MANAGEMENT, LLC | ARVINAS, INC. | 3,138,412 | 9.7% | EDGAR |
| SC 13G | 2019-02-14 | Crews Craig Martin | ARVINAS, INC. | 2,185,997 | 6.8% | EDGAR |
| SC 13G | 2019-02-13 | 5AM VENTURES III, L.P. | ARVINAS, INC. | 4,864,192 | 15.0% | EDGAR |
| SC 13G | 2019-02-13 | Nextech V Oncology S.C.S., SICAV-SIF | ARVINAS, INC. | 1,694,351 | 5.2% | EDGAR |
| SC 13G | 2019-01-24 | Canaan IX L.P. | ARVINAS, INC. | 4,989,554 | 15.4% | EDGAR |
| SC 13G | 2018-10-10 | ORBIMED ADVISORS LLC | ARVINAS INC. | 1,916,310 | 6.0% | EDGAR |